cichl.com

What It Is

Cichl is an AI tool for Korean medical institutions that helps review health insurance claims and reduce the risk of reimbursement cuts. It focuses on the reimbursement criteria, notices, administrative interpretations, and review cases from Korea’s Health Insurance Review & Assessment Service (HIRA). Before prescriptions are issued or claims are submitted, it performs a pre-review to help hospitals identify potential reduction risks and provides citable regulatory or case-based evidence.

Core Capabilities and Typical Use Cases

Users can enter diagnoses, prescriptions, billing codes, and related information. The system then evaluates them against HIRA rules and returns one of four outcomes: ALLOW, DENY, additional verification required, or insufficient information. It also attaches relevant notice numbers, administrative interpretations, or review case IDs. Common scenarios listed on the website include off-label prescriptions, inpatient necessity, appropriateness of patient cost-sharing ratios, and frequency limits for tests and procedures. Compared with manually searching through scattered documents, Cichl’s value lies in shortening the review time for each case and presenting the rationale directly. Compared with general-purpose LLMs, it emphasizes a specialized knowledge base, source citations, and continuous updates.

Pricing, Integration, and Privacy

The website does not disclose specific pricing, free trials, or plan tiers. It only provides options for “service use,” implementation consulting, and [email protected]. Current functionality appears to focus mainly on single-case review via the web. Integration with EMR systems, claims submission systems, and batch review likely needs to be negotiated based on deployment scale, and no public API information is available. On privacy, the site states that personally identifiable information is removed and that data is not used for purposes beyond processing requests. However, details such as storage, encryption, and access control would need to be agreed separately during implementation.

Pros, Cons, and Limitations

Its strengths are its very clear positioning and design around a real pain point in Korean health insurance claims. Each decision comes with supporting evidence, making it easier to review, verify, and appeal. It also covers multiple types of source material, including notices, administrative interpretations, and review cases. The main limitation is that public information remains relatively sparse: pricing, free usage limits, accuracy metrics, and the underlying model are not disclosed. Its output does not replace physicians’ clinical decision-making; it only addresses administrative compliance for claims review and still requires verification by professionals.

Who It’s For and Access from China

Cichl is mainly suited to Korean medical institutions, insurance claim teams, hospital review/compliance staff, and clinical departments looking to reduce reimbursement cut risks. Because its rule system is tightly tied to Korea’s HIRA framework, it is not directly applicable to China’s medical insurance scenarios. The website does not state whether it can be accessed or paid for from mainland China, so china_access can only be considered unknown. For the Chinese market, alternatives would typically be local medical insurance cost-control, DRG/DIP review systems, hospital internal prescription and billing review tools, or official medical insurance rule search combined with manual review.